Advertisement
Advertisement

S&P500: Healthcare Stocks Shine as Retail Earnings Drag Broader Market

By:
James Hyerczyk
Published: Nov 26, 2024, 15:41 GMT+00:00

Key Points:

  • S&P500 gains 0.1% as healthcare stocks rise; Dow drops 245 points, dragged down by Amgen’s 11% decline.
  • Healthcare stocks surge as Biden proposes Medicare, Medicaid coverage for weight-loss drugs.
  • Trump’s tariff proposals spark trade concerns, automaker stocks fall; Ford down 2%, GM tumbles 7%.
  • Kohl’s shares drop 17% after third-quarter earnings miss, with comparable sales falling 9.3%.
  • New home sales plunge 17% in October, missing forecasts as mortgage rates climb to 6.72%.
Nasdaq 100 Index, S&P 500 Index, Dow Jones

In this article:

What’s Driving the Stock Market Today?

Daily E-mini S&P 500 Index

The S&P 500 rose 0.1% on Tuesday as traders balanced optimism over year-end seasonality with concerns about President-elect Donald Trump’s proposed tariffs. While the Nasdaq Composite gained 0.3%, the Dow Jones Industrial Average dropped 245 points, or 0.6%, dragged down by Amgen’s steep decline.

Investors also monitored sector-specific moves, housing data, and new healthcare policy developments that could shape trading activity.

Broad Market Reacts to Tariff Proposals

Trump’s announcement of 25% tariffs on goods from Mexico and Canada, along with a 10% levy on Chinese products, introduced new trade uncertainty. Wall Street largely shrugged off the news, supported by favorable seasonal trends and robust earnings. Analysts, including Adam Crisafulli of Vital Knowledge, suggest skepticism about whether the tariffs will be fully implemented.

Automakers and ETFs Show Trade Sensitivity

Daily iShares MSCI Mexico ETF

Trade policy concerns hit automakers hard, with Ford and General Motors falling more than 2% and 7%, respectively. The iShares MSCI Mexico ETF (EWW), which tracks Mexican equities, dropped over 2%, reflecting heightened anxiety over trade relationships with Mexico.

Healthcare Stocks Jump on Policy News

Daily Eli Lilly and Company

Shares of Novo Nordisk and Eli Lilly rose 2% and 3%, respectively, after President Biden proposed Medicare and Medicaid coverage for weight-loss drugs like Wegovy and Zepbound. Analysts believe expanded coverage could significantly benefit these companies, though details about eligibility and implementation remain unclear.

Weak Home Sales Signal Housing Challenges

New home sales plummeted 17% in October, falling to 610,000 units and missing forecasts of 725,000. Rising mortgage rates, now at 6.72%, have dampened demand. Despite declining sales, median home prices climbed to $437,300, highlighting tight inventory as a factor in sustaining higher prices.

Retail Earnings Weigh on Sentiment

Daily Kohls Corporation

Kohl’s shares plunged 17% in premarket trading after the company missed third-quarter expectations. The retailer reported earnings of $0.20 per share on $3.51 billion in revenue, below consensus estimates of $0.28 per share and $3.64 billion. Comparable sales fell 9.3%, steeper than the expected 5.1% decline, contributing to the stock’s year-to-date loss of 36%.

Market Forecast: Where Could the Market Be Headed Next?

The market’s short-term outlook remains cautiously optimistic. While concerns over tariffs and weak retail performance weigh on sentiment, strong year-end seasonality and investor skepticism about aggressive trade measures could support further gains in the S&P 500. Key drivers this week will include Federal Reserve meeting minutes and reduced trading volumes ahead of the Thanksgiving holiday.

More Information in our Economic Calendar.

About the Author

James is a Florida-based technical analyst, market researcher, educator and trader with 35+ years of experience. He is an expert in the area of patterns, price and time analysis as it applies to futures, Forex, and stocks.

Advertisement